Last edition
News about "Letter of Intent "
Cipher Pharmaceuticals Secures pCPA Agreement to Expand Public Access to Epuris Across Canada
Cipher Pharmaceuticals has completed negotiations with the pan-Canadian Pharmaceutical Alliance, securing a Letter of Intent for Epuris (isotretinoin). The agreement represents a significant step toward expanding public drug plan coverage and improving patient access to severe acne treatment across Canada.
Letter Of Intent | 09/07/2026 | By News Bureau
Silo Pharma Signs LOI with Allucent for Phase I Development of SPC-15
Silo Pharma has executed a Letter of Intent (LoI) with Allucent to support the phase I clinical development of SPC-15, with planned single-ascending dose and multiple-ascending dose studies representing a key clinical milestone for its intranasal treatment targeting PTSD and anxiety disorders.
Letter Of Intent | 31/12/2025 | By News Bureau | 176
Miltenyi Biotec India, BIRAC Partner to Advance India's Cell and Gene Therapy Ecosystem
The partnership will focus on building local scientific capabilities, CAR-T clinical trials, addressing unmet medical needs and enhancing access through PoC manufacturing centres to strengthen India’s CGT capabilities.
Letter Of Intent | 19/06/2025 | By Abha | 361
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy